How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from Gatorade, Marriott, Alo Yoga, Campbell's, Uncommon James and more. Book now.
NEW YORK Four finalists are vying for the account of a new urinary incontinence drug from Eli Lilly & Co. and Boehringer Ingelheim, according to sources.
The estimated $25 million assignment is for ad duties outside the U.S.
Contending are WPP Group’s J. Walter Thompson in London, Omnicom Group’s BBDO in Dusseldorf, Germany, Interpublic Group’s Foote, Cone & Belding in New York and Havas’ Euro RSCG, London, sources said.
INDEPENDENCE DAY SALE
Subscribe today!
APPLY PROMO CODE "JULY20" AT CHECK OUT FOR 20% OFF
Already a member? Sign in